½ÃÀ庸°í¼­
»óǰÄÚµå
1421782

±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç° À¯Çüº°, ¾à¹° À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)

Dry Mouth Relief Market Share, Size, Trends, Industry Analysis Report, By Product Type (Mouthwash, Spray, Gel, Lozenges, and Others); By Drug Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 116 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 45¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

´Ù¾çÇÑ °ü·Ã ÁúȯÀÇ ±ÞÁõÀ¸·Î ÀÎÇÑ ±¸°­°ÇÁ¶Áõ ¹ßº´·ü Áõ°¡¿Í ±¸°­°ÇÁ¶Áõ Áõ»óÀ¸·ÎºÎÅÍ ½Å¼ÓÇÏ°í ºü¸£°Ô ¹þ¾î³¯ ¼ö ÀÖ´Â ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ÀÇ °¡¿ë¼º°ú ÀáÀçÀû ÀÌÁ¡¿¡ ´ëÇÑ »ç¶÷µéÀÇ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ ±¸°­Ã»°áÁ¦, ±¸°­Ã»°áÁ¦, °¡±Û, Á©, ½ºÇÁ·¹ÀÌ µî ±¸°­°ÇÁ¶Áõ Áõ»ó ¿ÏÈ­¸¦ À§ÇØ Æ¯º°È÷ °í¾ÈµÈ Á¦Ç° °³¹ßÀÇ Áö¼ÓÀûÀÎ Çõ½Å°ú ÇÔ²² ¼ÒºñÀÚ¿¡°Ô ´Ù¾çÇÑ ¼±ÅñÇÀ» Á¦°øÇÏ´Â °ÍÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 7¿ù K Pharmaceuticals´Â ±¸°­°ÇÁ¶Áõ ¿ÏÈ­¸¦ À§ÇØ ÀÓ»óÀûÀ¸·Î ÀÔÁõµÈ »õ·Î¿î ±¸°­ ½ºÇÁ·¹ÀÌÀÎ AquoralÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Ä¡·á¹ýÀº ȯÀÚ°¡ ÇÏ·ç¿¡ ÃÖ´ë 10ȸ±îÁö ¹Ýº¹ÀûÀ¸·Î Ç󱸰ųª ¹°¿¡ ¼¯¾î »ç¿ëÇÏ´Â Ä¡·á¹ýÀÔ´Ï´Ù.

Àü ¼¼°èÀûÀ¸·Î ¿ø°Ý ÀÇ·á Ç÷§ÆûÀÌ ÅëÇÕµÇ°í ´Ù¾çÇÑ ¿Â¶óÀÎ ÆÇ¸Å ä³ÎÀÌ µîÀåÇÏ¿© ´õ ¸¹Àº ûÁß°ú °í°´Ãþ¿¡°Ô ´Ù°¡°¥ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇϰí, ±â¾÷ÀÌ ¿ø°Ý ÀÇ·á ¼­ºñ½º¸¦ ÅëÇØ ¼ÒºñÀÚÀÇ Á¢±Ù¼º°ú ÆíÀǼºÀ» ³ôÀ̸鼭 »ó´ã°ú Á¦Ç° ÃßõÀ» Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù, °¡±î¿î ½ÃÀÏ ³»¿¡ ½ÃÀå¿¡ Å« ¼ºÀå °¡´É¼ºÀ» âÃâÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¶ÇÇÑ, ±¸°­°ÇÁ¶ÁõÀÇ ¿øÀΰú Ä¡·á ¹× Åõ¾à ¼Ö·ç¼Ç¿¡ ´ëÇØ ȯÀڵ鿡°Ô ¾Ë¸®°í ÀνĽÃ۱â À§ÇÑ ±³À° ÀÚ·á¿Í ÀÎ½Ä °³¼± Ä·ÆäÀÎÀ» ÁøÇàÇÏ´Â ¸¹Àº ȸ»çµéÀÌ ½ÃÀå¿¡ Á¸ÀçÇϸç, ÀûÀýÇÑ Á¦Ç°À» ã´Â ¼ÒºñÀÚµé »çÀÌ¿¡¼­ Å« ÁöÁö¸¦ ¾ò°í ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, TeleDentists´Â Ä¡°ú ÀÇ»ç, ±¸°­ °ü¸® Àü¹®°¡ ¹× Ä¡°ú À§»ý»ç¸¦ Áö¿øÇϱâ À§ÇØ ±¸°­ °ÇÁ¶Áõ, ÀÏ¸í ±¸°­ °ÇÁ¶Áõ¿¡ ´ëÇÑ Àü¹® ±³À° ¹× ÀÎ½Ä Á¦°í Ä·ÆäÀÎÀ» ½ÃÀÛÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

±¸°­°ÇÁ¶Áõ Áõ»óÀ» ºü¸£°Ô ¿ÏÈ­ÇÏ´Â ±¸°­Ã»°áÁ¦ »ç¿ë ±ÞÁõÀ¸·Î ±¸°­Ã»°áÁ¦ ºÎ¹®ÀÌ µÎµå·¯Áø ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÔ

ÁÖ·Î ÀÇ·á Àü¹®°¡°¡ ¾àÀ» ó¹æÇÒ ¼ö ÀÖ´Â º´¿ø ¹× Ŭ¸®´ÐÀÇ È¯ÀÚ ¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

ÀüÀÚ»ó°Å·¡ ºÐ¾ß´Â ½º¸¶Æ®Æù º¸±Þ·ü Áõ°¡¿Í ¿Â¶óÀÎ Ç÷§ÆûÀ¸·ÎÀÇ ÀüȯÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù.

ºÏ¹Ì´Â ±¸°­°ÇÁ¶Áõ À¯º´·üÀÌ ³ô°í °í·ÉÈ­ Àα¸°¡ Å©°Ô Áõ°¡Çϸ鼭 ¼¼°è ½ÃÀå¿¡¼­ Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ±â¾÷Àº Hikma Pharmaceuticals, Mission Pharmacal, Prestige Consumer Healthcare, Sun Pharmaceuticals µîÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå ÀλçÀÌÆ®

  • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - À¯Åë ä³Î ÇöȲ
  • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PESTEL ºÐ¼®
  • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå À¯Åë ä³Î µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, Á¦Ç° À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ±¸°­«Š°áÁ¦
  • ½ºÇÁ·¹ÀÌ
  • °Ö
  • ·ÎÁ¨Áö
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, ¾àÁ¦ À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¸ÅÀå
  • ó¹æ

Á¦7Àå ¼¼°èÀÇ ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, À¯Åë ä³Îº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¾à±¹
  • ½´ÆÛ¸¶ÄÏ/ÇÏÀÌÆÛ¸¶ÄÏ
  • E-Commerce ä³Î

Á¦8Àå ¼¼°èÀÇ ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
  • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • ºÏ¹Ì : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032³â
    • ºÏ¹Ì : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, ÀǾàǰ À¯Çüº°, 2019-2032³â
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ¹Ì±¹
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ij³ª´Ù
  • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - À¯·´
    • À¯·´ : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • À¯·´ : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032³â
    • À¯·´ : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019-2032³â
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ¿µ±¹
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ÇÁ¶û½º
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - µ¶ÀÏ
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ÀÌÅ»¸®¾Æ
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ½ºÆäÀÎ
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ³×´ú¶õµå
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ·¯½Ã¾Æ
  • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019-2032³â
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - Áß±¹
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - Àεµ
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ¸»·¹À̽þÆ
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ÀϺ»
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - Àεµ³×½Ã¾Æ
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - Çѱ¹
  • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019-2032³â
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - À̽º¶ó¿¤
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, À¯Åë ä³Îº°, 2019-2032
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019-2032³â
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ¸ß½ÃÄÚ
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ºê¶óÁú
    • ±¸°­°ÇÁ¶Áõ ¿ÏÈ­Á¦ ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦9Àå °æÀï ±¸µµ

  • È®Àå ¹× Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ °³¿ä

  • Acacia Pharma
  • Colgate-Palmolive
  • Dr. Fresh
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services Inc.
  • Lupin Pharmaceuticals Inc.
  • Mission Pharmacal Company
  • Parnell Pharmaceuticals Inc.
  • Prestige Consumer Healthcare Inc.
  • Procter & Gamble
  • Sanofi
  • Sun Pharmaceuticals Industries Ltd.
  • Wisconsin Pharmacal Company
  • Xlear
LSH 24.02.19

The global dry mouth relief market size is expected to reach USD 4.58 billion by 2032, according to a new study by Polaris Market Research. The report "Dry Mouth Relief Market Share, Size, Trends, Industry Analysis Report, By Product Type (Mouthwash, Spray, Gel, Lozenges, and Others); By Drug Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising incidences of dry mouth that is mainly driven by surge in the prevalence of various associated diseases and increasing people awareness about the availability and potential benefits of dry mouth relief to get quick and rapid relief from their dry mouth symptoms, are prominent factors boosting the market growth. Additionally, with the continuous increase in innovation in product development including mouthwashes, lozenges, gels, and sprays specifically designed to alleviate dry mouth symptoms, while offering consumers a variety of options to choose from, has been pushing the market growth forward.

For instance, in July 2023, K Pharmaceuticals, announced the launch of Aquoral, a new clinically proven oral spray for dry mouth relief. It is a different type of treatment method that require patients to rinse & repeat up to 10 times a day or also to be mixed with the water.

The rising integration of telehealth platforms around the world and emergence of various online sales channels providing an opportunity to reach a wider audience and customer base, and allowing companies to offer consultations and product recommendations through telehealth services while enhancing accessibility and convenience for consumers, is also likely to generate huge growth potential for the market in the near future.

Furthermore, there are numerous companies in the market who are focusing on creating educational resources and awareness campaigns to inform and aware patients about the causes of dry mouth and the available treatment and medication solutions, which has been gaining huge traction among consumers seeking appropriate products.

For instance, The TeleDentists, announced the launch of a professional educational and awareness campaign on xerostomia which is also known as dry mouth, that is designed to help dentists, oral care professionals, and dental hygienists.

Dry Mouth Relief Market Report Highlights

Mouthwash segment accounted for noteworthy market share, on account of its surging use to provide quick relief from dry mouth symptoms

Prescribed segment held the majority market share, mainly due to growing patient pool in hospitals and clinics where healthcare professionals might prescribe medications

E-commerce segment will grow at highest pace, that is driven by increased smartphone penetration and rising number of people shifting towards online platforms

North America dominated the global market with substantial share, owing to greater prevalence of xerostomia and significant increase in region's aging population

The key market players include Hikma Pharmaceuticals, Mission Pharmacal, Prestige Consumer Healthcare, and Sun Pharmaceuticals

Polaris Market Research has segmented the dry mouth relief market report based on product type, drug type, distribution channel, and region:

Dry Mouth Relief, Product Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Mouthwash
  • Spray
  • Gel
  • Lozenges
  • Others

Dry Mouth Relief, Drug Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Over-the-counter
  • Prescribed

Dry Mouth Relief, Distribution Channel Outlook (Revenue - USD Billion, 2023 - 2032)

  • Pharmacies
  • Supermarkets & Hypermarket
  • E-commerce Channels

Dry Mouth Relief, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dry Mouth Relief Market Insights

  • 4.1. Dry Mouth Relief Market - Distribution Channel Snapshot
  • 4.2. Dry Mouth Relief Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of chronic disorders and autoimmune disorders boosting the market growth
      • 4.2.1.2. Innovations in Product Development
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The availability of limited treatment options may restrict market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Dry Mouth Relief Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dry Mouth Relief Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
  • 5.3. Mouthwash
    • 5.3.1. Global Dry Mouth Relief Market, by Mouthwash, by Region, 2019-2032 (USD Billion)
  • 5.4. Spray
    • 5.4.1. Global Dry Mouth Relief Market, by Spray, by Region, 2019-2032 (USD Billion)
  • 5.5. Gel
    • 5.5.1. Global Dry Mouth Relief Market, by Gel, by Region, 2019-2032 (USD Billion)
  • 5.6. Lozenges
    • 5.6.1. Global Dry Mouth Relief Market, by Lozenges, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Dry Mouth Relief Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Dry Mouth Relief Market, by Drug Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
  • 6.3. Over-the-counter
    • 6.3.1. Global Dry Mouth Relief Market, by Over-the-counter, by Region, 2019-2032 (USD Billion)
  • 6.4. Prescribed
    • 6.4.1. Global Dry Mouth Relief Market, by Prescribed, by Region, 2019-2032 (USD Billion)

7. Global Dry Mouth Relief Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Pharmacies
    • 7.3.1. Global Dry Mouth Relief Market, by Pharmacies, By Region, 2019-2032 (USD Billion)
  • 7.4. Supermarket & Hypermarket
    • 7.4.1. Global Dry Mouth Relief Market, by Supermarket & Hypermarket, By Region, 2019-2032 (USD Billion)
  • 7.5. E-commerce Channels
    • 7.5.1. Global Dry Mouth Relief Market, by E-commerce Channels, By Region, 2019-2032 (USD Billion)

8. Global Dry Mouth Relief Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Dry Mouth Relief Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Dry Mouth Relief Market - North America
    • 8.3.1. North America: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.3.4. Dry Mouth Relief Market - U.S.
      • 8.3.4.1. U.S.: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.3.5. Dry Mouth Relief Market - Canada
      • 8.3.5.1. Canada: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
  • 8.4. Dry Mouth Relief Market - Europe
    • 8.4.1. Europe: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.4. Dry Mouth Relief Market - UK
      • 8.4.4.1. UK: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.5. Dry Mouth Relief Market - France
      • 8.4.5.1. France: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.6. Dry Mouth Relief Market - Germany
      • 8.4.6.1. Germany: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.7. Dry Mouth Relief Market - Italy
      • 8.4.7.1. Italy: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.8. Dry Mouth Relief Market - Spain
      • 8.4.8.1. Spain: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.9. Dry Mouth Relief Market - Netherlands
      • 8.4.9.1. Netherlands: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.10. Dry Mouth Relief Market - Russia
      • 8.4.10.1. Russia: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
  • 8.5. Dry Mouth Relief Market - Asia Pacific
    • 8.5.1. Asia Pacific: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.4. Dry Mouth Relief Market - China
      • 8.5.4.1. China: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.5. Dry Mouth Relief Market - India
      • 8.5.5.1. India: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.6. Dry Mouth Relief Market - Malaysia
      • 8.5.6.1. Malaysia: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.7. Dry Mouth Relief Market - Japan
      • 8.5.7.1. Japan: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.8. Dry Mouth Relief Market - Indonesia
      • 8.5.8.1. Indonesia: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.9. Dry Mouth Relief Market - South Korea
      • 8.5.9.1. South Korea: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
  • 8.6. Dry Mouth Relief Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.4. Dry Mouth Relief Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.5. Dry Mouth Relief Market - UAE
      • 8.6.5.1. UAE: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.6. Dry Mouth Relief Market - Israel
      • 8.6.6.1. Israel: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.7. Dry Mouth Relief Market - South Africa
      • 8.6.7.1. South Africa: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
  • 8.7. Dry Mouth Relief Market - Latin America
    • 8.7.1. Latin America: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.4. Dry Mouth Relief Market - Mexico
      • 8.7.4.1. Mexico: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.5. Dry Mouth Relief Market - Brazil
      • 8.7.5.1. Brazil: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.6. Dry Mouth Relief Market - Argentina
      • 8.7.6.1. Argentina: Dry Mouth Relief Market, by Product Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Dry Mouth Relief Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Dry Mouth Relief Market, by Drug Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Acacia Pharma
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Colgate-Palmolive
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Dr. Fresh
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Hikma Pharmaceuticals PLC
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Johnson & Johnson Services Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Lupin Pharmaceuticals Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mission Pharmacal Company
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Parnell Pharmaceuticals Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Prestige Consumer Healthcare Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Procter & Gamble
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Sanofi
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sun Pharmaceuticals Industries Ltd.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Wisconsin Pharmacal Company
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Xlear
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦